Newsletter

Monkey Head

Total Labels 1
Approved 1
Expired 0

MEXCOR, INC. — HOUSTON, TX

France

About Monkey Head

Monkey Head is a vodka brand with origin recorded in France. The spirit is classified as an 80 to 89 proof vodka, placing it in the standard strength category for the category. According to TTB public records, the brand maintains one distinct product offering currently available in the market. The brand received its initial TTB label approval in 2020, marking its entry into the United States spirits market during that year. With a single approved label on record, Monkey Head represents a focused product line within the vodka category. The French origin designation distinguishes it within the broader vodka market, which has traditionally been dominated by spirits from Eastern European and Russian-speaking regions. As a vodka product in the 80 to 89 proof range, it falls within the conventional alcohol by volume specifications that define most standard vodka offerings. The brand's regulatory presence in the TTB COLA registry confirms its legal status for sale and distribution in the United States market. Details regarding the specific characteristics, production methods, or regional provenance within France are not available from the public registration records maintained by the Alcohol and Tobacco Tax and Trade Bureau.

Filter by:
Displaying 1 results
Label Name Spirit Type Status Approval Date Producer
Vodka 80-89 Proof Fb
Monkey Head

VODKA 80-89 PROOF FB

Vodka 80-89 Proof Fb Approved 2020-10-27 MEXCOR, INC.

Page 1 of 1

1

Monkey Head at a Glance

Monkey Head has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof Fb. Labels approved between 2020-10-27 and 2020-10-27. Produced in France.

All information sourced from public TTB records.

Are you the owner or distributor of Monkey Head?

Claim this brand listing to update information or get featured. Contact [email protected].

Produced At

Mexcor, INC.

Related Brands

Related Questions

Browse All Labels

Stay informed

Newsletter coming soon.

Follow us on X for new approvals, launches, and industry intelligence.